Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Recommendation of “Buy” by Brokerages

Stevanato Group S.p.A. (NYSE:STVN) has been given a consensus rating of “Buy” by the six ratings firms that are covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating, two have issued a buy rating and two have given a strong buy rating to the company.

A number of research analysts recently weighed in on STVN shares. TD Cowen raised shares of Stevanato Group to a “strong-buy” rating in a report on Wednesday, June 17th. Weiss Ratings raised shares of Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 27th. Finally, Wolfe Research began coverage on shares of Stevanato Group in a research report on Tuesday, June 2nd. They set an “outperform” rating and a $21.00 price objective for the company.

Insider Activity

In related news, Director Karen Flynn sold 1,493 shares of the stock in a transaction dated Monday, June 15th. The shares were sold at an average price of €17.09, for a total value of €25,515.37. Following the completion of the transaction, the director owned 5,757 shares of the company’s stock, valued at approximately €98,387.13. This trade represents a 20.59% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Luciano Santel sold 2,023 shares of Stevanato Group stock in a transaction dated Friday, August 7th. The stock was sold at an average price of €20.09, for a total value of €40,642.07. Following the completion of the transaction, the director owned 4,739 shares of the company’s stock, valued at approximately €95,206.51. This represents a 29.92% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 14,249 shares of company stock worth $268,346.

Institutional Trading of Stevanato Group

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Conestoga Capital Advisors LLC lifted its position in shares of Stevanato Group by 7.6% during the first quarter. Conestoga Capital Advisors LLC now owns 8,491,751 shares of the company’s stock worth $116,762,000 after purchasing an additional 602,050 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its stake in Stevanato Group by 10.4% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 3,923,632 shares of the company’s stock worth $78,944,000 after acquiring an additional 368,792 shares in the last quarter. TimesSquare Capital Management LLC grew its stake in Stevanato Group by 7.1% in the 4th quarter. TimesSquare Capital Management LLC now owns 3,500,321 shares of the company’s stock worth $70,426,000 after acquiring an additional 232,645 shares in the last quarter. Bamco Inc. NY increased its position in shares of Stevanato Group by 1.4% during the fourth quarter. Bamco Inc. NY now owns 2,001,724 shares of the company’s stock worth $40,275,000 after acquiring an additional 27,965 shares during the period. Finally, Wellington Management Group LLP purchased a new position in shares of Stevanato Group during the second quarter worth approximately $22,621,000.

Stevanato Group Price Performance

NYSE STVN opened at €20.32 on Friday. The stock’s 50 day moving average is €20.44 and its 200 day moving average is €17.76. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.21. Stevanato Group has a 12 month low of €12.89 and a 12 month high of €28.00. The stock has a market cap of $6.15 billion, a PE ratio of 36.29, a P/E/G ratio of 1.63 and a beta of 0.75.

Stevanato Group (NYSE:STVN) last posted its quarterly earnings results on Wednesday, August 5th. The company reported €0.14 earnings per share for the quarter, missing the consensus estimate of €0.15 by (€0.01). Stevanato Group had a return on equity of 10.43% and a net margin of 10.99%.The business had revenue of €302.00 million during the quarter. Research analysts predict that Stevanato Group will post 0.71 EPS for the current fiscal year.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.